qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

This blog post reviews molecular point-of-care (POC) diagnostic platforms included in the most recent edition of the report The Market and Potential for Molecular Point of Care Diagnostics. Kalorama Information offers related titles with qPCR and dPCR Markets , The World Market for Infectious Disease Diagnostic Tests , and The World Market for Molecular Diagnostics.

Contributing a high amount of growth to the clinical IVD market over the past decade, molecular diagnostics is established in ref...

  • by bcarlson@marketresearch.com
  • February 18 2016
  • EHR


Between Flint and Ransomware, Good and Bad News for EMR

Between Flint and Ransomware, Good and Bad News for EMR

Depending on the news one reads, this was either an unfavorable month for the 25 billion-dollar electronic medical records (EMR) industry , or it was its finest hour. The industry demonstrated its prowess in dealing with a community medical issue that would have been failed by paper records, but also had some negative publicity on IT security.

First, this month brought news that the lead poisoning water crisis in Flint, Michigan was discovered as the result of searches conducted using data fro...


Infectious Disease Updates - Zika Virus, Lyme Disease and the U.S. Influenza Season

Infectious Disease Updates - Zika Virus, Lyme Disease and the U.S. Influenza Season

Kalorama Information offers complete analysis of the global infectious disease diagnostics market with its recent title The World Market for Infectious Disease Diagnostic Tests. Previous posts in this blog reviewed infectious disease test market segments for hospital-acquired infections (HAIs); antimicrobial resistance ; women’s health and sexually transmitted pathogens , hepatitis , HIV/AIDS , and respiratory tract infection tests.

Influenza in the United States

The United States is experie...


The Liquid Biopsy: The Promise and Challenge behind CTCs and cfDNA

The Liquid Biopsy: The Promise and Challenge behind CTCs and cfDNA

Kalorama Information offers comprehensive analysis of the cancer diagnostics market, including cancer testing services, with The World Market for Cancer Diagnostics, 6 th Edition. Liquid biopsy technology is also reviewed in The World Market for Molecular Diagnostics, 6 th Edition. A free Kalorama Information white paper regarding the market for laboratory-developed oncology tests is available here.

The localization of disease can make diagnostic insights inaccessible by routine IVD testing fo...


POC Juggernaut Forged with Alere Purchase

POC Juggernaut Forged with Alere Purchase

Abbott is marking out point-of-care as an area that it can compete and win in with its purchase of Waltham, MA-based Alere, Inc. This should not be surprising as POC in some areas , such as infectious disease, is growing revenue at one and one-half times the global IVD market. POC testing is a target area for IVD companies because of better-than-average revenue growth in most areas. We think that Abbott was already a significant competitor in point-of-care testing, but the purchase of Alere puts...